lavendamycin has been researched along with Malignant Melanoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boger, DL; Drake, SD; Kitos, PA; Mitscher, LA; Thompson, SC; Yasuda, M | 1 |
1 other study(ies) available for lavendamycin and Malignant Melanoma
Article | Year |
---|---|
Streptonigrin and lavendamycin partial structures. Probes for the minimum, potent pharmacophore of streptonigrin, lavendamycin, and synthetic quinoline-5,8-diones.
Topics: Animals; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry, Physical; Leukemia L1210; Melanoma; Mice; Microbial Sensitivity Tests; Quinolines; Streptonigrin; Structure-Activity Relationship | 1987 |